CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $565.71M, above the global median of $520.53M
- FinancialsAltman Z-Score 3.46: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.52%Below 5Y avg (1.82%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
13.6%Sustainable
Payback Period
63.8 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.06BCNY900.08M · vs all stocks (USD)
Trailing P/E
21.80xvs Medical Instruments & Supplies peers
Revenue (TTM)
3.81BCNY565.71M · vs all stocks (USD)
Profit Margin
7.12%vs Medical Instruments & Supplies peers
Beta
0.2300xvs all stocks
52-Week Change
-2.15%vs all stocks
Market Capitalization
6.06BCNY900.08M · vs all stocks (USD)
Enterprise Value
5.98BCNY887.77M · vs all stocks (USD)
Trailing P/E
21.80xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.59xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.60xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.57xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
7.09xvs Medical Instruments & Supplies peers
Gross Margin
32.67%vs Medical Instruments & Supplies peers
Profit Margin
7.12%vs Medical Instruments & Supplies peers
Operating Margin
16.73%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.87%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
7.83%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.81BCNY565.71M · vs all stocks (USD)
Revenue per Share (TTM)
6.20CNYUpdated Aug 20, 2026Quarterly Revenue Growth
18.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.13BCNY167.29M · vs all stocks (USD)
EBITDA (TTM)
545.06MCNY80.95M · vs all stocks (USD)
Net Income (TTM)
271.33MCNY40.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
26.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
572.63MCNY85.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
123.03MCNY18.27M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1460CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.52%vs all stocks
5-Year Average Dividend Yield
1.82%vs all stocks
Payout Ratio
13.56%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
19.77MCNYFY2025 · Dec 31, 2025Revenue
3.67BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.62BCNYFY2025 · Dec 31, 2025Gross Profit
1.05BCNYFY2025 · Dec 31, 2025Operating Income
594.90MCNY88.35M · vs all stocks (USD)
Pre-tax Income
309.02MCNYFY2025 · Dec 31, 2025Income Tax Expense
51.87MCNYFY2025 · Dec 31, 2025Net Income
257.15MCNYFY2025 · Dec 31, 2025EBIT
326.69MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
812.92MCNYFY2025 · Dec 31, 2025Research & Development
104.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
122.11MCNYFY2025 · Dec 31, 2025Other Operating Expenses
33.15MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
16.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
17.67MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4022CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4022CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
257.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-8.26MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
82.46MCNYFY2025 · Dec 31, 2025Free Cash Flow
-177.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
965.72MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
257.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
33.09MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-120.22MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-87.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-260.31MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.19BCNYFY2025 · Dec 31, 2025Sale of Investments
1.18BCNYFY2025 · Dec 31, 2025Other Investing Activity
3.61MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-266.09MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
594.01MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-637.35MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-52.34MCNYFY2025 · Dec 31, 2025Other Financing Charges
30.51MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-65.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
633.27MSharesUpdated Aug 20, 2026Float Shares
363.96MSharesUpdated Aug 20, 2026% Held by Insiders
62.43%vs all stocks
% Held by Institutions
3.70%vs all stocks
Total Cash (MRQ)
770.06MCNY114.37M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.25CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.02BCNY152.14M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2753xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.84xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.01CNYUpdated Aug 20, 2026Total Assets
5.61BCNY832.78M · vs all stocks (USD)
Total Current Assets
2.40BCNYFY2025 · Dec 31, 2025Total Liabilities
1.99BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.20BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
663.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.33BCNYFY2025 · Dec 31, 2025Cash
965.18MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
967.62MCNYFY2025 · Dec 31, 2025Other Short-term Investments
4.56MCNYFY2025 · Dec 31, 2025Accounts Receivable
517.70MCNYFY2025 · Dec 31, 2025Inventory
720.30MCNYFY2025 · Dec 31, 2025Accounts Payable
476.22MCNYFY2025 · Dec 31, 2025Short-term Debt
634.24MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.21MCNYFY2025 · Dec 31, 2025Long-term Debt
173.34MCNYFY2025 · Dec 31, 2025Common Stock (Book)
633.27MCNYFY2025 · Dec 31, 2025Retained Earnings
2.25BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.61BCNY536.87M · vs all stocks (USD)
Treasury Stock
148.52MCNYFY2025 · Dec 31, 202552-Week Low
8.33CNYUpdated Aug 20, 202652-Week High
14.90CNYUpdated Aug 20, 202652-Week Change
-2.15%vs all stocks
Beta
0.2300xvs all stocks
50-Day MA
9.22CNYUpdated Aug 20, 2026200-Day MA
11.06CNYUpdated Aug 20, 2026Avg 10-Day Volume
7.47MSharesUpdated Aug 20, 2026Avg 30-Day Volume
8.20MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.4400CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.46: safe zoneNotable
Altman Z-Score: 3.46
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $565.71M, above the global median of $520.53MNotable
Revenue (USD): 565,713,735.086Global Median: 520,528,949.311
Levered free cash flow is $18.27M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,273,129.684Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Techshine Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Zigong Conveying Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Çimsa Çimento Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Hailide New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Star Shuaier Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Tony Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Opko Health Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Ta Ya Electric Wire & Cable Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangxi Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Boshijie Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Celestica Inc.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Boyd Gaming Corporation
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Shandong Himile Mechanical Co., Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated